666 related articles for article (PubMed ID: 24314850)
1. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
Steinhausen HC; Bisgaard C
Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
[TBL] [Abstract][Full Text] [Related]
2. The association between medication for attention-deficit/hyperactivity disorder and cancer.
Steinhausen HC; Helenius D
J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):208-13. PubMed ID: 23560601
[TBL] [Abstract][Full Text] [Related]
3. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
Kollins SH
Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
[TBL] [Abstract][Full Text] [Related]
4. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
[TBL] [Abstract][Full Text] [Related]
6. Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives.
Skoglund C; Chen Q; Franck J; Lichtenstein P; Larsson H
Biol Psychiatry; 2015 May; 77(10):880-6. PubMed ID: 25457227
[TBL] [Abstract][Full Text] [Related]
7. [Substance use disorders and ADHD: an overview of recent Dutch research].
van Emmerik-van Oortmerssen K; Crunelle CL; Carpentier PJ
Tijdschr Psychiatr; 2013; 55(11):861-6. PubMed ID: 24242145
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for secondary substance use disorders in people with childhood and adolescent-onset bipolar disorder: opportunities for prevention.
Kenneson A; Funderburk JS; Maisto SA
Compr Psychiatry; 2013 Jul; 54(5):439-46. PubMed ID: 23332720
[TBL] [Abstract][Full Text] [Related]
9. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
Upadhyaya HP
J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
[TBL] [Abstract][Full Text] [Related]
10. Attention deficit hyperactivity disorder and substance use disorders.
Szobot CM; Bukstein O
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study.
Arvidsson M; Dahl ML; Franck J; Wiig EH; Nielsen NP
Nord J Psychiatry; 2019 Feb; 73(2):118-124. PubMed ID: 30861357
[TBL] [Abstract][Full Text] [Related]
12. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability.
Sizoo B; van den Brink W; Koeter M; Gorissen van Eenige M; van Wijngaarden-Cremers P; van der Gaag RJ
Drug Alcohol Depend; 2010 Feb; 107(1):44-50. PubMed ID: 19786328
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis.
Castells X; Ramos-Quiroga JA; Rigau D; Bosch R; Nogueira M; Vidal X; Casas M
CNS Drugs; 2011 Feb; 25(2):157-69. PubMed ID: 21254791
[TBL] [Abstract][Full Text] [Related]
14. Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults.
Nogueira M; Bosch R; Valero S; Gómez-Barros N; Palomar G; Richarte V; Corrales M; Nasillo V; Vidal R; Casas M; Ramos-Quiroga JA
Compr Psychiatry; 2014 Apr; 55(3):639-49. PubMed ID: 24411652
[TBL] [Abstract][Full Text] [Related]
15. Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
Ottosen C; Petersen L; Larsen JT; Dalsgaard S
J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):227-34.e4. PubMed ID: 26903256
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
[TBL] [Abstract][Full Text] [Related]
17. Substance use disorder and ADHD: is ADHD a particularly "specific" risk factor?
Kousha M; Shahrivar Z; Alaghband-Rad J
J Atten Disord; 2012 May; 16(4):325-32. PubMed ID: 22127397
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders.
Skoglund C; Brandt L; Almqvist C; DʼOnofrio BM; Konstenius M; Franck J; Larsson H
J Clin Psychopharmacol; 2016 Jun; 36(3):222-8. PubMed ID: 27043119
[TBL] [Abstract][Full Text] [Related]
19. Attention-deficit/hyperactivity disorder: a life-span perspective.
Biederman J
J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
Simon N; Rolland B; Karila L
Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
